首页 | 本学科首页   官方微博 | 高级检索  
     


Case Report: Octreotide as an Adjunct to Embolisation in the Management of Recurrent Bleeding Upper Gastrointestinal Metastases from PrimaryRenal Cell Cancer
Authors:Gavin?W.?A.?Lamb  author-information"  >  author-information__contact u-icon-before"  >  mailto:glam@doctors.org.uk"   title="  glam@doctors.org.uk"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Jon?Moss,Richard?Edwards,Michael?Aitchison
Affiliation:(1) Department of Radiology, Gartnavel General Hospital, 1053 Great Western Road, G12 0YN Glasgow, UK;(2) Department of Urology, Gartnavel General Hospital, 1053 Great Western Road, G12 0YN Glasgow, UK;(3) “Bracadale”, 29 Station Road, Killearn, Stirlingshire, G63 9NZ, UK
Abstract:The recommended treatment for patients with severe bleeding from upper gastrointestinal (GI) metastases is embolisation. We report a case in which despite adequate embolisation major haemorrhage from renal cell carcinoma (RCC) gastric metastases continually recurred. During a severe bleed refractory to embolisation octreotide was used to control and prevent further bleeding. No further episodes of severe haemorrhage occurred over the following 23 months since starting treatment. Octreotide has been observed to be effective both in the acute management of persistent haemorrhage and in prevention of subsequent haematemesis from GI metastatic RCC.
Keywords:Embolisation  Gastrointestinal metastases  Haematemesis  Octreotide  Renal cell carcinoma
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号